Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax)Ìýpresents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extendedÌýversion with links to references, examples and case studiesÌý
  • Read the article in Pharmaceutical TechnologyÌýÌý

Ìý

Also in the Knowledge Center

Related Content

Global Sales and Marketing Meeting - GSM 2023

Hi there! Find here the relevant information about the Global Sales, Marketing & Communications and PMO Meeting in Lisbon, Portugal.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more